UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000044912
Receipt No. R000051295
Scientific Title Multicenter clinical study for intravaginal ejaculation disorder with use of a masturbation aid
Date of disclosure of the study information 2021/07/20
Last modified on 2021/11/25 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Multicenter clinical study for intravaginal ejaculation disorder with use of a masturbation aid
Acronym clinical study for intravaginal ejaculation disorder with use of a masturbation aid
Scientific Title Multicenter clinical study for intravaginal ejaculation disorder with use of a masturbation aid
Scientific Title:Acronym clinical study for intravaginal ejaculation disorder with use of a masturbation aid
Region
Japan

Condition
Condition intravaginal ejaculation disorder
Classification by specialty
Urology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 intravaginal ejaculation
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes intravaginal ejaculation
Key secondary outcomes International Index of Erectile Function, EHS, Male Sexual Health Questionnaire for assessing ejaculatory dysfunction, Confidence in Performing Sexual Intercourse Questionnaire-12, Numerical Rating Scale

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
60 years-old >=
Gender Male
Key inclusion criteria bother with intravaginal ejaculation disorder
one sexual partner
continuing sexual intercourse
Key exclusion criteria diabetes that is difficult to control
neurogenic disease
penile skin trouble
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Akira
Middle name
Last name Tsujimura
Organization Juntendo University Urayasu Hospital
Division name Department of Urology
Zip code 2790021
Address 2-1-1, Tomioka, Urayasu city, Chiba, Japan
TEL +81473533111
Email atsujimu@juntendo.ac.jp

Public contact
Name of contact person
1st name MASATO
Middle name
Last name SHIRAI
Organization Juntendo University Urayasu Hospital
Division name Department of Urology
Zip code 2790021
Address 2-1-1, Tomioka, Urayasu city, Chiba, Japan
TEL +81473533111
Homepage URL
Email masatos@juntendo-urayasu.jp

Sponsor
Institute Juntendo University Urayasu Hospital
Institute
Department

Funding Source
Organization self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor Iwasa Clinic
Name of secondary funder(s)

IRB Contact (For public release)
Organization Institutional Review Board, Juntendo University Urayasu Hospital
Address 2-1-1, Tomioka, Urayasu City, Chiba, Japan
Tel +81-47-353-3111
Email rinri-urayasu@juntendo-urayasu.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 順天堂大学浦安病院(千葉県)Juntendo University Urayasu Hospital
岩佐クリニック (大阪府) Iwasa clinic
Dクリニック東京メンズヘルス(東京都)D clinic, Tokyo Men's

Other administrative information
Date of disclosure of the study information
2021 Year 07 Month 20 Day

Related information
URL releasing protocol
Publication of results Partially published

Result
URL related to results and publications
Number of participants that the trial has enrolled 15
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2020 Year 04 Month 14 Day
Date of IRB
2020 Year 04 Month 14 Day
Anticipated trial start date
2020 Year 04 Month 14 Day
Last follow-up date
2021 Year 11 Month 30 Day
Date of closure to data entry
2021 Year 11 Month 30 Day
Date trial data considered complete
2021 Year 11 Month 30 Day
Date analysis concluded
2021 Year 11 Month 30 Day

Other
Other related information study duration is 2-month

Management information
Registered date
2021 Year 07 Month 20 Day
Last modified on
2021 Year 11 Month 25 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051295